Molecular basis of class A β-lactamase inhibition by relebactam
β-Lactamase production is the major β-lactam resistance mechanism in Gram-negative bacteria. β-Lactamase inhibitors (BLIs) efficacious against serine β-lactamase (SBL) producers, especially strains carrying the widely disseminated class A enzymes, are required. Relebactam, a diazabicyclooctane (DBO)...
Main Authors: | Tooke, C, Hinchlifee, P, Lang, P, Mulholland, A, Brem, J, Schofield, C, Spencer, J |
---|---|
Format: | Journal article |
Published: |
American Society for Microbiology
2019
|
Similar Items
-
Cyclic boronates as versatile scaffolds for KPC-2 β-lactamase inhibition
by: Tooke, C, et al.
Published: (2020) -
Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates
by: Brem, J, et al.
Published: (2016) -
Cyclic Boronates Inhibit All Classes of β-Lactamase.
by: Cahill, S, et al.
Published: (2017) -
A new mechanism for β-lactamases: Class D enzymes degrade 1β-methyl carbapenems through lactone formation
by: Lohans, C, et al.
Published: (2018) -
Structural basis of metallo-β-lactamase inhibition by captopril stereoisomers
by: Brem, J, et al.
Published: (2015)